| pubmed-article:11094868 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:11094868 | lifeskim:mentions | umls-concept:C0086418 | lld:lifeskim |
| pubmed-article:11094868 | lifeskim:mentions | umls-concept:C0085295 | lld:lifeskim |
| pubmed-article:11094868 | lifeskim:mentions | umls-concept:C0024264 | lld:lifeskim |
| pubmed-article:11094868 | lifeskim:mentions | umls-concept:C0021390 | lld:lifeskim |
| pubmed-article:11094868 | lifeskim:mentions | umls-concept:C0031437 | lld:lifeskim |
| pubmed-article:11094868 | lifeskim:mentions | umls-concept:C1280500 | lld:lifeskim |
| pubmed-article:11094868 | lifeskim:mentions | umls-concept:C1155000 | lld:lifeskim |
| pubmed-article:11094868 | lifeskim:mentions | umls-concept:C2745888 | lld:lifeskim |
| pubmed-article:11094868 | lifeskim:mentions | umls-concept:C1515655 | lld:lifeskim |
| pubmed-article:11094868 | pubmed:issue | 6 | lld:pubmed |
| pubmed-article:11094868 | pubmed:dateCreated | 2000-12-22 | lld:pubmed |
| pubmed-article:11094868 | pubmed:abstractText | Interleukin-10 (IL-10) exhibits potent anti-inflammatory and immunosuppressive activities in vitro. Recent data indicate that treatment with recombinant human IL-10 (rHuIL-10) Crohn's disease is safe and may induce clinical and endoscopic remission. The present study investigates the in vivo immunomodulatory properties of rHuIL-10 in inflammatory bowel disease (IBD). | lld:pubmed |
| pubmed-article:11094868 | pubmed:language | eng | lld:pubmed |
| pubmed-article:11094868 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:11094868 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:11094868 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:11094868 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:11094868 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:11094868 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:11094868 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:11094868 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:11094868 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:11094868 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:11094868 | pubmed:month | Nov | lld:pubmed |
| pubmed-article:11094868 | pubmed:issn | 1081-5589 | lld:pubmed |
| pubmed-article:11094868 | pubmed:author | pubmed-author:KuhsLL | lld:pubmed |
| pubmed-article:11094868 | pubmed:author | pubmed-author:TillMM | lld:pubmed |
| pubmed-article:11094868 | pubmed:author | pubmed-author:ReinischWW | lld:pubmed |
| pubmed-article:11094868 | pubmed:author | pubmed-author:Lichtenberger... | lld:pubmed |
| pubmed-article:11094868 | pubmed:author | pubmed-author:GascheCC | lld:pubmed |
| pubmed-article:11094868 | pubmed:author | pubmed-author:DejacoCC | lld:pubmed |
| pubmed-article:11094868 | pubmed:author | pubmed-author:WaldhoerTT | lld:pubmed |
| pubmed-article:11094868 | pubmed:issnType | Print | lld:pubmed |
| pubmed-article:11094868 | pubmed:volume | 48 | lld:pubmed |
| pubmed-article:11094868 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:11094868 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:11094868 | pubmed:pagination | 449-56 | lld:pubmed |
| pubmed-article:11094868 | pubmed:dateRevised | 2006-11-15 | lld:pubmed |
| pubmed-article:11094868 | pubmed:meshHeading | pubmed-meshheading:11094868... | lld:pubmed |
| pubmed-article:11094868 | pubmed:meshHeading | pubmed-meshheading:11094868... | lld:pubmed |
| pubmed-article:11094868 | pubmed:meshHeading | pubmed-meshheading:11094868... | lld:pubmed |
| pubmed-article:11094868 | pubmed:meshHeading | pubmed-meshheading:11094868... | lld:pubmed |
| pubmed-article:11094868 | pubmed:meshHeading | pubmed-meshheading:11094868... | lld:pubmed |
| pubmed-article:11094868 | pubmed:meshHeading | pubmed-meshheading:11094868... | lld:pubmed |
| pubmed-article:11094868 | pubmed:meshHeading | pubmed-meshheading:11094868... | lld:pubmed |
| pubmed-article:11094868 | pubmed:meshHeading | pubmed-meshheading:11094868... | lld:pubmed |
| pubmed-article:11094868 | pubmed:meshHeading | pubmed-meshheading:11094868... | lld:pubmed |
| pubmed-article:11094868 | pubmed:meshHeading | pubmed-meshheading:11094868... | lld:pubmed |
| pubmed-article:11094868 | pubmed:meshHeading | pubmed-meshheading:11094868... | lld:pubmed |
| pubmed-article:11094868 | pubmed:meshHeading | pubmed-meshheading:11094868... | lld:pubmed |
| pubmed-article:11094868 | pubmed:meshHeading | pubmed-meshheading:11094868... | lld:pubmed |
| pubmed-article:11094868 | pubmed:meshHeading | pubmed-meshheading:11094868... | lld:pubmed |
| pubmed-article:11094868 | pubmed:meshHeading | pubmed-meshheading:11094868... | lld:pubmed |
| pubmed-article:11094868 | pubmed:meshHeading | pubmed-meshheading:11094868... | lld:pubmed |
| pubmed-article:11094868 | pubmed:year | 2000 | lld:pubmed |
| pubmed-article:11094868 | pubmed:articleTitle | In vivo effects of recombinant human interleukin-10 on lymphocyte phenotypes and leukocyte activation markers in inflammatory bowel disease. | lld:pubmed |
| pubmed-article:11094868 | pubmed:affiliation | Department of Internal Medicine IV, University of Vienna, Austria. clemens.dejaco@akh-wien.ac.at | lld:pubmed |
| pubmed-article:11094868 | pubmed:publicationType | Journal Article | lld:pubmed |
| pubmed-article:11094868 | pubmed:publicationType | Clinical Trial | lld:pubmed |
| pubmed-article:11094868 | pubmed:publicationType | Randomized Controlled Trial | lld:pubmed |
| pubmed-article:11094868 | pubmed:publicationType | Research Support, Non-U.S. Gov't | lld:pubmed |
